Coya Therapeutics opened lower at $3.19, compared with its previous close of $3.21. In the last trading session, the stock traded between $3.05 and $3.41. It showed an upward intraday trend.
Return calculator
Time Period
An investment of $100 made 4 years ago in Coya Therapeutics is now worth
$ 71.51
Resulting in a loss of
$ 28.49 (28.49%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 4 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
+$0.06 (+1.81%)
Day High
$3.41
Day Low
$3.05
Day Open
$3.19
Prev Close
$3.21
Volume
1,29,823
1W Return
5.76%
1M Return
-32.16%
3M Return
-32.13%
6M Return
-21.82%
1Y Return
-45.62%
Fundamentals
Market Cap ($ Mn)
77
PE Ratio
-
PB Ratio
2.49
PEG Ratio
-
ROE
-61.86%
ROCE
-60.30%
EPS (TTM)
$-0.45
Investment Returns
1 Week
5.76%
1 Month
-32.16%
3 Months
-32.13%
6 Months
-21.82%
9 Months
-33.71%
Financials
Quarterly
All values in $ Mn
0.3
Mar 25
0.2
Jun 25
3.6
Sep 25
4.0
Dec 25
0.2
Jun 26
0.2
Sep 26
Updates
14Oct
Coya Therapeutics plans open-label extension for ALS drug COYA 302
Coya Therapeutics initiates open-label extension for ALS trial COYA 302 in November 2026. FTD Phase 2 trial start date delayed to 2027 from second half of 2026. Cash runway guidance unchanged, funding operations into second half of 2027. Resource prioritization focuses on ALSTARS trial completion and data readout.
29 days ago
15Jun
Coya Therapeutics to host webinar on head trauma and neurodegenerative disease
Coya Therapeutics announced a live webinar for June 24, 2026, discussing the link between repetitive head trauma and neurodegenerative diseases like CTE and ALS. Moderated by Solomon Wilcots, the event features experts Dr. Stanley H. Appel, Dr. Fred Grossman, and Leigh Steinberg. The company focuses on Treg-based therapies for neuroinflammation.
